Abdominal obesity modifies long-term associations between periodontitis and markers of systemic inflammation

Atherosclerosis

Volumn 235, Issue 2, 2014, Pages 351-357

  Gocke, Christiane ^a   Holtfreter, Birte ^a   Meisel, Peter ^a   Grotevendt, Anne ^a   Jablonowski, Lukasz ^a   Nauck, Matthias ^a   Markus, Marcello Ricardo Paulista ^a   Kocher, Thomas ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

Cohort study; Fibrinogen; Obesity; Periodontitis; Study of health in Pomerania; Systemic inflammation; White blood cell count

Indexed keywords

FIBRINOGEN;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HUMAN; INFLAMMATION; LEUKOCYTE; LEUKOCYTE COUNT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PERIODONTITIS; POPULATION RESEARCH; PRIORITY JOURNAL; SYSTEMIC DISEASE; ATHEROSCLEROSIS; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; GERMANY; MIDDLE AGED; RISK FACTOR;

ADULT; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; FEMALE; GERMANY; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; PERIODONTITIS; RISK FACTORS;

EID: 84921480162     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.05.926     Document Type: Article

References (43)

1. World Health Organization The top 10 causes of death 2013, Available from:, [accessed 07.10.13]. http://who.int/mediacentre/factsheets/fs310/en/index.html.
2. Holtfreter B., Schwahn C., Biffar R., Kocher T. Epidemiology of periodontal diseases in the Study of Health in Pomerania. JClin Periodontol 2009, 36(2):114-123.
3. Tonetti M.S., Van Dyke T.E. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. JPeriodontol 2013, 84(4 Suppl):S24-S29.
4. Dietrich T., Sharma P., Walter C., Weston P., Beck J. The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. JPeriodontol 2013, 84(4 Suppl):S70-S84.
5. Bahekar A.A., Singh S., Saha S., Molnar J., Arora R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 2007, 154(5):830-837.
6. Dietrich T., Jimenez M., Krall Kaye E.A., Vokonas P.S., Garcia R.I. Age-dependent associations between chronic periodontitis/edentulism and risk of coronary heart disease. Circulation 2008, 117(13):1668-1674.
7. Van Dyke T.E., van Winkelhoff A.J. Infection and inflammatory mechanisms. JClin Periodontol 2013, 40(Suppl.14):S1-S7.
8. Schenkein H.A., Loos B.G. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. JClin Periodontol 2013, 40(Suppl.14):S51-S69.
9. Kebschull M., Demmer R.T., Papapanou P.N. "Gum bug, leave my heart alone!" - epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. JDent Res 2010, 89(9):879-902.
10. Forner L., Larsen T., Kilian M., Holmstrup P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. JClin Periodontol 2006, 33(6):401-407.
11. Lafaurie G.I., Mayorga-Fayad I., Torres M.F., Castillo D.M., Aya M.R., Baron A., et al. Periodontopathic microorganisms in peripheric blood after scaling and root planing. JClin Periodontol 2007, 34(10):873-879.
12. Kozarov E., Sweier D., Shelburne C., Progulske-Fox A., Lopatin D. Detection of bacterial DNA in atheromatous plaques by quantitative PCR. Microbes Infect 2006, 8(3):687-693.
13. Monteiro A.M., Jardini M.A.N., Alves S., Giampaoli V., Aubin E.C.Q., Figueiredo Neto A.M., et al. Cardiovascular disease parameters in periodontitis. JPeriodontol 2009, 80(3):378-388.
14. Shi D., Meng H., Xu L., Zhang L., Chen Z., Feng X., et al. Systemic inflammation markers in patients with aggressive periodontitis: a pilot study. JPeriodontol 2008, 79(12):2340-2346.
15. Buhlin K., Hultin M., Norderyd O., Persson L., Pockley A.G., Rabe P., et al. Risk factors for atherosclerosis in cases with severe periodontitis. JClin Periodontol 2009, 36(7):541-549.
16. Salzberg T.N., Overstreet B.T., Rogers J.D., Califano J.V., Best A.M., Schenkein H.A. C-reactive protein levels in patients with aggressive periodontitis. JPeriodontol 2006, 77(6):933-939.
17. Slade G.D., Ghezzi E.M., Heiss G., Beck J.D., Riche E., Offenbacher S. Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis Risk in Communities study. Arch Intern Med 2003, 163(10):1172-1179.
18. Vidal F., Figueredo C.M.S., Cordovil I., Fischer R.G. periodontal therapy reduces plasma levels of interleukin-6, C-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. JPeriodontol 2009, 80(5):786-791.
19. Radafshar G., Shad B., Ariamajd E., Geranmayeh S. Effect of intensive non-surgical treatment on the level of serum inflammatory markers in advanced periodontitis. JDent (Tehran) 2010, 7(1):24-30.
20. Offenbacher S., Beck J.D., Moss K., Mendoza L., Paquette D.W., Barrow D.A., et al. Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. JPeriodontol 2009, 80(2):190-201.
21. Demmer R.T., Trinquart L., Zuk A., Fu B.C., Blomkvist J., Michalowicz B.S., et al. The influence of anti-infective periodontal treatment on C-reactive protein: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2013, 8(10):e77441.
22. Teeuw W.J., Slot D.E., Susanto H., Gerdes V.E., Abbas F., D'Aiuto F., et al. Treatment of periodontitis improves the atherosclerotic profile: a systematic review and meta-analysis. JClin Periodontol 2014, 41(1):70-79.
23. Paraskevas S., Huizinga J.D., Loos B.G. Asystematic review and meta-analyses on C-reactive protein in relation to periodontitis. JClin Periodontol 2008, 35(4):277-290.
24. Volzke H., Alte D., Schmidt C.O., Radke D., Lorbeer R., Friedrich N., et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol 2011, 40(2):294-307.
25. Hensel E., Gesch D., Biffar R., Bernhardt O., Kocher T., Splieth C., et al. Study of Health in Pomerania (SHIP): a health survey in an East German region. Objectives and design of the oral health section. Quintessence Int 2003, 34(5):370-378.
26. John U., Greiner B., Hensel E., Ludemann J., Piek M., Sauer S., et al. Study of Health in Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Praventivmed 2001, 46(3):186-194.
27. Alte D., Ludemann J., Piek M., Adam C., Rose H.J., John U. Distribution and dose response of laboratory markers to alcohol consumption in a general population: results of the Study of Health in Pomerania (SHIP). JStud Alcohol 2003, 64(1):75-82.
28. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120(16):1640-1645.
29. Adamu A.N. Comparative performance of HbA1c 6.5% for FPG ≥7.0 vs 2hr PG≥11.1 criteria for diagnosis of type 2 diabetes. Afr Health Sci 2011, 11(3):421-426.
30. Demmer R.T., Kocher T., Schwahn C., Volzke H., Jacobs D.R., Desvarieux M. Refining exposure definitions for studies of periodontal disease and systemic disease associations. Community Dent Oral Epidemiol 2008, 36(6):493-502.
31. Gatke D., Holtfreter B., Biffar R., Kocher T. Five-year change of periodontal diseases in the Study of Health in Pomerania (SHIP). JClin Periodontol 2012, 39(4):357-367.
32. Salazar M.G., Jehmlich N., Murr A., Dhople V.M., Holtfreter B., Hammer E., et al. Identification of periodontitis associated changes in the proteome of whole human saliva by mass spectrometric analysis. JClin Periodontol 2013, 40(9):825-832.
33. Holtfreter B., Alte D., Schwahn C., Desvarieux M., Kocher T. Effects of different manual periodontal probes on periodontal measurements. JClin Periodontol 2012, 39(11):1032-1041.
34. Greenland S., Brumback B. An overview of relations among causal modelling methods. Int J Epidemiol 2002, 31(5):1030-1037.
35. Textor J., Hardt J., Knuppel S. DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology 2011, 22(5):745.
36. Hopkins M.H., Owen J., Ahearn T., Fedirko V., Flanders W.D., Jones D.P., et al. Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial. Cancer Prev Res (Phila) 2011, 4(10):1645-1654.
37. StataCorp Stata statistical software: release 13 2013, StataCorp LP, College Station, TX.
38. Sinning J.M., Bickel C., Messow C.M., Schnabel R., Lubos E., Rupprecht H.J., et al. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study. Eur Heart J 2006, 27(24):2962-2968.
39. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107(3):363-369.
40. Wheeler J.G., Mussolino M.E., Gillum R.F., Danesh J. Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J 2004, 25(15):1287-1292.
41. Brown D.W., Giles W.H., Croft J.B. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. JClin Epidemiol 2001, 54(3):316-322.
42. Beck J.D., Offenbacher S. Relationships among clinical measures of periodontal disease and their associations with systemic markers. Ann Periodontol 2002, 7(1):79-89.
43. Fantuzzi G. Adipose tissue, adipokines, and inflammation. JAllergy Clin Immunol 2005, 115(5):911-919. quiz 920.